Ultrasound AI Inc.

Ultrasound AI is a healthcare technology company founded in 2019 that develops AI-powered software tools for maternal and neonatal healthcare. The company's flagship product, Delivery Date AI™, uses artificial intelligence trained on over 8 million ultrasound images to accurately predict delivery dates in singleton pregnancies (14–36 weeks gestation) where a reliable estimated delivery date is unavailable. Delivery Date AI™ received FDA De Novo authorization in 2026 and is currently approved for clinical use in the United States, Brazil, and Chile. The company also developed Preterm AI™, designed to identify risks of preterm birth and enable proactive clinical interventions. Ultrasound AI holds six issued patents across three countries and positions its solutions as decision-support tools that augment clinician judgment in obstetric care, addressing the critical clinical need for accurate pregnancy dating to improve maternal and neonatal outcomes.